QuantRx Biomedical Corporation Selects Synova Healthcare Inc. As The Exclusive Distributor Of Its PAD Technology -- To Be Used For The Treatment Of Hemorrhoids
7/17/2006 12:13:14 PM
QuantRx® Biomedical Corporation (OTCBB: QTXB) announced today that it has entered into an exclusive distribution agreement for its PAD technology with Synova Healthcare, a distributor of diagnostic products. Under this agreement, QuantRx® received an up-front payment of $500,000 and is eligible to receive royalties, based upon sales, estimated to be worth multi-million dollars, over the term of the multi-year agreement in return for granting Synova exclusive rights to distribute the PAD technology for sales of Hemorrhoid Products in North America.
comments powered by